Brief: Profound Medical Q2 EPS USD -0.52
14/08/2025 21:05
Aug 14 (Reuters) - Profound Medical Q2 revenue USD 3 million vs. IBES estimate USD 3.53 million. Q2 net income USD -15.7 million Q2 operating expenses USD 15.4 million
- CA$300.17m
- CA$252.95m
- $16.10m